Generic AML drug shows promise in bioequivalence study
Disease control
Completed
This study tested whether a generic version of the drug azacitidine works the same as the brand-name drug Onureg® in adults with acute myeloid leukemia (AML). Thirty-two participants who were in remission after initial chemotherapy took single doses of both tablets under fasting …
Phase: PHASE1 • Sponsor: Hikma Pharmaceuticals LLC • Aim: Disease control
Last updated May 17, 2026 06:38 UTC